Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Selective progesterone receptor modulators in early stage breast cancer: a randomized, placebo-controlled Phase II window of opportunity trial using telapristone acetate.

Lee O, Sullivan ME, Xu Y, Rodgers C, Muzzio M, Helenowski I, Shidfar A, Zeng Z, Singhal H, Jovanovic B, Hansen N, Bethke KP, Gann PH, Gradishar W, Kim JJ, Clare SE, Khan SA.

Clin Cancer Res. 2019 Sep 30. pii: clincanres.0443.2019. doi: 10.1158/1078-0432.CCR-19-0443. [Epub ahead of print]

PMID:
31570566
2.

Assessment of hospital-level adjusted breast cancer sentinel lymph node positivity rates.

Berger ER, Bilimoria KY, Kinnier CV, Minami CA, Bethke KP, Hansen NM, Merkow RP, Winchester DP, Yang AD.

J Surg Oncol. 2019 Jan;119(1):101-108. doi: 10.1002/jso.25294. Epub 2018 Nov 27.

PMID:
30481371
3.

Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.

Paudel N, Bethke KP, Wang LC, Strauss JB, Hayes JP, Donnelly ED.

Surg Oncol. 2018 Mar;27(1):95-99. doi: 10.1016/j.suronc.2018.01.001. Epub 2018 Jan 8.

PMID:
29549911
4.

Development of a nomogram to predict the clinical impact of a postexcision preirradiation mammogram.

Donnelly ED, Neuschler E, Henley C, Helenowski I, Hansen N, Khan SA, Bethke K, Gutiontov S, Nesbit E, Hayes J, Strauss JB.

Breast J. 2018 Jul;24(4):620-623. doi: 10.1111/tbj.12974. Epub 2017 Dec 29.

PMID:
29286191
5.

The Surgical Impact of E-Cigarettes: A Case Report and Review of the Current Literature.

Fracol M, Dorfman R, Janes L, Kulkarni S, Bethke K, Hansen N, Kim J.

Arch Plast Surg. 2017 Nov;44(6):477-481. doi: 10.5999/aps.2017.00087. Epub 2017 Oct 26. Review.

6.

A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?

Abbott AM, Valente SA, Loftus L, Tendulkar RD, Greif JM, Bethke KP, Donnelly ED, Lottich C, Ross DL, Friedman NB, Bedi CG, Joh JE, Kelemen P, Hoefer RA, Kang SK, Ruffer J, Police A, Fyles A, Graves GM, Willey SC, Tousimis EA, Small W, Lyons J, Grobmyer S, Laronga C.

Am J Surg. 2017 Oct;214(4):629-633. doi: 10.1016/j.amjsurg.2017.06.018. Epub 2017 Jun 23.

PMID:
28918848
7.

In Situ Complementary Doping, Thermoelectric Improvements, and Strain-Induced Structure within Alternating PEDOT:PSS/PANI Layers.

Andrei V, Bethke K, Madzharova F, Bronneberg AC, Kneipp J, Rademann K.

ACS Appl Mater Interfaces. 2017 Sep 27;9(38):33308-33316. doi: 10.1021/acsami.7b10106. Epub 2017 Sep 14.

PMID:
28870076
8.

Tamoxifen Acceptance and Adherence among Patients with Ductal Carcinoma In Situ (DCIS) Treated in a Multidisciplinary Setting.

Karavites LC, Kane AK, Zaveri S, Xu Y, Helenowski I, Hansen N, Bethke KP, Rasmussen-Torvik LJ, Khan SA.

Cancer Prev Res (Phila). 2017 Jul;10(7):389-397. doi: 10.1158/1940-6207.CAPR-17-0029. Epub 2017 May 30.

9.

Assessing long-term complications in patients undergoing immediate postmastectomy breast reconstruction and adjuvant radiation.

Sacotte R, Fine N, Kim JY, Alghoul M, Bethke K, Hansen N, Khan SA, Kulkarni S, Strauss J, Hayes JP, Donnelly ED.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):e91-e97. doi: 10.1016/j.prro.2016.10.017. Epub 2016 Oct 30.

PMID:
28274406
10.

Risk Factors Leading to Complications in Early-Stage Breast Cancer Following Breast-Conserving Surgery and Intraoperative Radiotherapy.

Rakhra S, Bethke K, Strauss J, Hayes JP, Hansen N, Khan SA, Helenowski I, Donnelly ED.

Ann Surg Oncol. 2017 May;24(5):1258-1261. doi: 10.1245/s10434-016-5679-0. Epub 2016 Nov 16.

PMID:
27853900
11.

National Evaluation of the New Commission on Cancer Quality Measure for Postmastectomy Radiation Treatment for Breast Cancer.

Minami CA, Bilimoria KY, Hansen NM, Strauss JB, Hayes JP, Feinglass JM, Bethke KP, Rydzewski NR, Winchester DP, Palis BE, Yang AD.

Ann Surg Oncol. 2016 Aug;23(8):2446-55. doi: 10.1245/s10434-016-5257-5. Epub 2016 May 11.

PMID:
27169774
12.

TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer.

Valente SA, Tendulkar RD, Cherian S, O'Rourke C, Greif JM, Bailey L, Uhl V, Bethke KP, Donnelly ED, Rudolph R, Pederson A, Summer T, Lottich SC, Ross DL, Laronga C, Loftus L, Abbott AM, Kelemen P, Hermanto U, Friedman NB, Bedi GC, Joh JE, Thompson WA 3rd, Hoefer RA, Wilson JP, Kang SK, Rosen B, Ruffer J, Bravo L, Police A, Escallon JM, Fyles AW, McCready DR, Graves GM, Rohatgi N, Eaker JA, Graves J, Willey SC, Tousimis EA, Collins BT, Shaw CM, Riley L, Deb N, Kelly T, Andolino DL, Boisvert ME, Lyons J, Small W Jr, Grobmyer SR.

Ann Surg Oncol. 2016 Sep;23(9):2809-15. doi: 10.1245/s10434-016-5240-1. Epub 2016 May 9.

PMID:
27160524
13.

Decreasing the Effective Thermal Conductivity in Glass Supported Thermoelectric Layers.

Bethke K, Andrei V, Rademann K.

PLoS One. 2016 Mar 16;11(3):e0151708. doi: 10.1371/journal.pone.0151708. eCollection 2016.

14.

Adjusting the thermoelectric properties of copper(I) oxide-graphite-polymer pastes and the applications of such flexible composites.

Andrei V, Bethke K, Rademann K.

Phys Chem Chem Phys. 2016 Apr 28;18(16):10700-7. doi: 10.1039/c5cp06828b.

PMID:
26967595
15.

Cytologic atypia in the contralateral unaffected breast is related to parity and estrogen-related genes.

Monahan DA, Wang J, Lee O, Revesz E, Taft N, Ivancic D, Hansen NM, Bethke KP, Zalles C, Khan SA.

Surg Oncol. 2016 Dec;25(4):449-456. doi: 10.1016/j.suronc.2015.12.001. Epub 2015 Dec 30.

PMID:
26856771
16.

Clinical outcomes with the MammoSite radiation therapy system: results of a prospective trial.

Small W Jr, Refaat T, Strauss JB, Gopalakrishnan M, Bethke KP, Mendelson EB, Wolfman JA, Jovanovic BD, Kiel K.

J Radiat Oncol. 2015 Dec;4(4):395-400. Epub 2015 Nov 2.

17.

Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation.

Lee O, Ivancic D, Allu S, Shidfar A, Kenney K, Helenowski I, Sullivan ME, Muzzio M, Scholtens D, Chatterton RT Jr, Bethke KP, Hansen NM, Khan SA.

Cancer Chemother Pharmacol. 2015 Dec;76(6):1235-46. doi: 10.1007/s00280-015-2848-y. Epub 2015 Nov 11.

PMID:
26560487
18.

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579).

Kaklamani VG, Jeruss JS, Hughes E, Siziopikou K, Timms KM, Gutin A, Abkevich V, Sangale Z, Solimeno C, Brown KL, Jones J, Hartman AR, Meservey C, Jovanovic B, Helenowski I, Khan SA, Bethke K, Hansen N, Uthe R, Giordano S, Rosen S, Hoskins K, Von Roenn J, Jain S, Parini V, Gradishar W.

Breast Cancer Res Treat. 2015 Jun;151(3):629-38. doi: 10.1007/s10549-015-3435-y. Epub 2015 May 26.

PMID:
26006067
19.

A Multi-institutional Analysis of Insurance Status as a Predictor of Morbidity Following Breast Reconstruction.

Vieira BL, Lanier ST, Mlodinow AS, Bethke KP, Murphy RX Jr, Hume KM, Gutowski KA, Fine NA, Kim JY.

Plast Reconstr Surg Glob Open. 2014 Dec 5;2(11):e255. doi: 10.1097/GOX.0000000000000207. eCollection 2014 Nov.

20.

A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.

Lee O, Page K, Ivancic D, Helenowski I, Parini V, Sullivan ME, Margenthaler JA, Chatterton RT Jr, Jovanovic B, Dunn BK, Heckman-Stoddard BM, Foster K, Muzzio M, Shklovskaya J, Skripkauskas S, Kulesza P, Green D, Hansen NM, Bethke KP, Jeruss JS, Bergan R, Khan SA.

Clin Cancer Res. 2014 Jul 15;20(14):3672-82. doi: 10.1158/1078-0432.CCR-13-3045.

21.

Individualized risk of surgical-site infection: an application of the breast reconstruction risk assessment score.

Kim JY, Khavanin N, Jordan SW, ver Halen JP, Mlodinow AS, Bethke KP, Khan SA, Hansen NM, Losken A, Fine NA.

Plast Reconstr Surg. 2014 Sep;134(3):351e-362e. doi: 10.1097/PRS.0000000000000439.

PMID:
24814422
22.

Risk factors for unplanned readmissions following excisional breast surgery.

Khavanin N, Bethke KP, Lovecchio FC, Jeruss JS, Hansen NM, Kim JY.

Breast J. 2014 May-Jun;20(3):288-94. doi: 10.1111/tbj.12253. Epub 2014 Apr 2.

PMID:
24689860
23.

Abstract 46: The BRA Score: Creating a General Risk Calculator for Breast Reconstruction Outcomes.

Khavanin N, Kim JY, Davila AA, Ver Halen JP, Mlodinow AS, Bethke KP, Khan SA, Jeruss JS, Hansen NM, Bilimoria KY, Losken A, Fine NA.

Plast Reconstr Surg. 2014 Mar;133(3 Suppl):56-7. doi: 10.1097/01.prs.0000445079.93837.65. No abstract available.

PMID:
25942157
24.

Post-mastectomy reconstruction: a risk-stratified comparative analysis of outcomes.

Saha D, Davila AA, Ver Halen JP, Jain UK, Hansen N, Bethke K, Khan SA, Jeruss J, Fine N, Kim jY.

Breast. 2013 Dec;22(6):1072-80.

25.

Tumescent technique does not increase the risk of complication following mastectomy with immediate reconstruction.

Khavanin N, Fine NA, Bethke KP, Mlodinow AS, Khan SA, Jeruss JS, Hansen NM, Kim JY.

Ann Surg Oncol. 2014 Feb;21(2):384-8. doi: 10.1245/s10434-013-3311-0. Epub 2013 Oct 12.

PMID:
24121881
26.

Reply: To PMID 23211118.

Gart MS, Smetona JT, Hanwright PJ, Fine NA, Bethke KP, Khan SA, Kim JY.

J Am Coll Surg. 2013 Jul;217(1):174-5. doi: 10.1016/j.jamcollsurg.2013.04.022. No abstract available.

PMID:
23791294
27.

Two surgeons, one patient: the impact of surgeon-surgeon familiarity on patient outcomes following mastectomy with immediate reconstruction.

Seth AK, Hirsch EM, Kim JY, Bethke KP, Hansen NM, Fine NA.

Breast. 2013 Oct;22(5):914-8. doi: 10.1016/j.breast.2013.04.013. Epub 2013 May 11.

28.

Lipid metabolism genes in contralateral unaffected breast and estrogen receptor status of breast cancer.

Wang J, Scholtens D, Holko M, Ivancic D, Lee O, Hu H, Chatterton RT Jr, Sullivan ME, Hansen N, Bethke K, Zalles CM, Khan SA.

Cancer Prev Res (Phila). 2013 Apr;6(4):321-30. doi: 10.1158/1940-6207.CAPR-12-0304. Epub 2013 Mar 19.

29.

Effect of MRI on the management of ductal carcinoma in situ of the breast.

Pilewskie M, Kennedy C, Shappell C, Helenowski I, Scholtens D, Hansen N, Bethke K, Jeruss J, Karstaedt P, Khan SA.

Ann Surg Oncol. 2013 May;20(5):1522-9. doi: 10.1245/s10434-012-2771-y. Epub 2012 Dec 7.

PMID:
23224903
30.

Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program.

Gart MS, Smetona JT, Hanwright PJ, Fine NA, Bethke KP, Khan SA, Wang E, Kim JY.

J Am Coll Surg. 2013 Feb;216(2):229-38. doi: 10.1016/j.jamcollsurg.2012.11.003. Epub 2012 Dec 2. Erratum in: J Am Coll Surg. 2013 May;216(5):1034-5.

PMID:
23211118
31.

A geometric analysis of mastectomy incisions: Optimizing intraoperative breast volume.

Chopp D, Rawlani V, Ellis M, Johnson SA, Buck DW 2nd, Khan S, Bethke K, Hansen N, Kim JY.

Can J Plast Surg. 2011 Summer;19(2):45-50.

32.

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen NM, Bethke KP, Dew A, Coomes M, Bergan RC.

Cancer Prev Res (Phila). 2012 Feb;5(2):309-19. doi: 10.1158/1940-6207.CAPR-11-0251.

33.

Association between recency of last pregnancy and biologic subtype of breast cancer.

Pilewskie M, Gorodinsky P, Fought A, Hansen N, Bethke K, Jeruss J, Scholtens D, Khan SA.

Ann Surg Oncol. 2012 Apr;19(4):1167-73. doi: 10.1245/s10434-011-2104-6. Epub 2011 Oct 14.

PMID:
21997350
34.

Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib.

Kaklamani VG, Siziopikou K, Scholtens D, Lacouture M, Gordon J, Uthe R, Meservey C, Hansen N, Khan SA, Jeruss JS, Bethke K, Cianfrocca M, Rosen S, Von Roenn J, Wayne J, Parimi V, Jovanovic B, Gradishar W.

Breast Cancer Res Treat. 2012 Apr;132(3):833-42. doi: 10.1007/s10549-011-1411-8. Epub 2011 Feb 27.

PMID:
21359953
35.

Acellular dermis-assisted breast reconstruction with the use of crescentric tissue expansion: a functional cosmetic analysis of 40 consecutive patients.

Buck DW 2nd, Heyer K, DiBardino D, Bethke K, Kim JY.

Aesthet Surg J. 2010 Mar;30(2):194-200. doi: 10.1177/1090820X10366547.

PMID:
20442096
36.

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ.

J Clin Oncol. 2009 Jun 20;27(18):2946-53. doi: 10.1200/JCO.2008.19.5750. Epub 2009 Apr 13.

PMID:
19364968
37.

Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers.

Bilimoria KY, Cambic A, Hansen NM, Bethke KP.

Arch Surg. 2007 May;142(5):441-5; discussion 445-7.

PMID:
17515485
38.

Ductal lavage findings in women with known breast cancer undergoing mastectomy.

Khan SA, Wiley EL, Rodriguez N, Baird C, Ramakrishnan R, Nayar R, Bryk M, Bethke KB, Staradub VL, Wolfman J, Rademaker A, Ljung BM, Morrow M.

J Natl Cancer Inst. 2004 Oct 20;96(20):1510-7.

PMID:
15494601
39.

Cross-presentation of human melanoma peptide antigen MART-1 to CTLs from in vitro reconstituted gp96/MART-1 complexes.

Staib F, Distler M, Bethke K, Schmitt U, Galle PR, Heike M.

Cancer Immun. 2004 Apr 16;4:3.

40.

Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60.

Bethke K, Staib F, Distler M, Schmitt U, Jonuleit H, Enk AH, Galle PR, Heike M.

J Immunol. 2002 Dec 1;169(11):6141-8.

41.

Learning sentinel node biopsy: results of a prospective randomized trial of two techniques.

Morrow M, Rademaker AW, Bethke KP, Talamonti MS, Dawes LG, Clauson J, Hansen N.

Surgery. 1999 Oct;126(4):714-20; discussion 720-2.

PMID:
10520920
42.

Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines.

Heike M, Weinmann A, Bethke K, Galle PR.

Biochem Pharmacol. 1999 Nov 1;58(9):1381-7.

PMID:
10513981
43.

Breast conservation: predictors and treatment of local recurrence.

Bethke KP.

Semin Surg Oncol. 1996 Sep-Oct;12(5):332-8. Review.

PMID:
8873321
44.

Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx.

Frank JL, Garb JL, Kay S, McClish DK, Bethke KP, Lind DS, Mellis M, Slomka W, Sismanis A, Neifeld JP.

Am J Surg. 1994 Nov;168(5):476-80.

PMID:
7977979
45.

Expansion and tumour specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients.

Lind DS, Tuttle TM, Bethke KP, Frank JL, McCrady CW, Bear HD.

Surg Oncol. 1993 Oct;2(5):273-82.

PMID:
8305969
46.

Activation of CD8+ murine T cells from tumor-draining lymph nodes by phorbol dibutyrate plus calcium ionophore.

Tuttle TM, Inge TH, McCrady CM, Bethke KP, Bear HD.

J Immunother (1991). 1992 Jul;12(1):32-40.

PMID:
1386251
47.

Bryostatin 1-activated T cells can traffic and mediate tumor regression.

Tuttle TM, Bethke KP, Inge TH, McCrady CW, Pettit GR, Bear HD.

J Surg Res. 1992 Jun;52(6):543-8.

PMID:
1528028
48.

Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1.

Tuttle TM, Inge TH, Bethke KP, McCrady CW, Pettit GR, Bear HD.

Cancer Res. 1992 Feb 1;52(3):548-53.

49.

Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide.

Inge TH, Hoover SK, Frank JL, Kawabata TT, Bethke KP, Bear HD.

Cancer Immunol Immunother. 1992;35(2):119-26.

PMID:
1534514
50.

Diagnosis and management of sacrococcygeal chordoma.

Bethke KP, Neifeld JP, Lawrence W Jr.

J Surg Oncol. 1991 Dec;48(4):232-8. Review.

PMID:
1745047

Supplemental Content

Loading ...
Support Center